Insider Trading July 1, 2026 05:16 PM

BETA Technologies Executive Kyle Clark Executes Pre-Arranged Stock Sales Amidst Stock Decline

Analysis of recent insider transactions, financial performance, and analyst adjustments for BETA Technologies.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
BETA

Kyle Clark, President and CEO of BETA Technologies, Inc. (NASDAQ:BETA), recently executed a series of stock sales totaling approximately $494,691. The transactions were facilitated through The Godric’s Hollow Trust under a pre-established 10b5-1 trading plan. This activity occurs as BETA Technologies navigates a challenging market environment, with its stock price declining approximately 54% over the past year to $17.38. The company recently reported Q1 2026 earnings that showed a larger-than-expected loss per share, though revenue met expectations. Additionally, analysts from BTIG and Cantor Fitzgerald have adjusted their price targets for BETA, reflecting a complex outlook for the company.

BETA Technologies Executive Kyle Clark Executes Pre-Arranged Stock Sales Amidst Stock Decline
BETA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Kyle Clark, President and CEO of BETA Technologies, sold 30,000 shares via The Godric’s Hollow Trust under a 10b5-1 plan, totaling approximately $494,691.
  • BETA Technologies reported Q1 2026 earnings with a loss per share of -$0.53, missing the forecasted -$0.45, though revenue of $10.1 million exceeded expectations.
  • Analysts from BTIG and Cantor Fitzgerald adjusted their price targets for BETA to $33 and $31 respectively, while maintaining positive ratings based on strategic certification plans.

Kyle Clark, serving as both President and Chief Executive Officer of BETA Technologies, Inc. (NASDAQ:BETA), has executed a significant divestment of company shares. Over two separate transactions on June 29 and June 30, 2026, Mr. Clark disposed of a total of 30,000 shares of the company's Class A common stock. The aggregate value of these sales reached approximately $494,691.

The initial transaction took place on June 29, 2026, where Mr. Clark sold 15,000 shares. These shares were traded at a weighted average price of $16.3836 per share. The execution of this sale involved multiple transactions within a specific price range, spanning from $16.10 to $17.00 per share. The following day, June 30, 2026, Mr. Clark completed a second transaction, selling an additional 15,000 shares. This second batch of shares was sold at a weighted average price of $16.5958 per share, with individual sales occurring within a narrower price band between $16.20 and $16.84.

Both transactions were not executed directly by Mr. Clark but were facilitated by The Godric’s Hollow Trust, an entity affiliated with him. The sales were conducted pursuant to a pre-established 10b5-1 trading plan, a mechanism often used by executives to manage insider trading regulations. Mr. Clark has disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest.

Following the completion of these sales, The Godric’s Hollow Trust retains a substantial position in the company, holding 5,569,837 shares of Class A common stock. Mr. Clark's direct holdings include 748,915 shares of Class A common stock. Furthermore, indirect holdings are distributed among other entities and individuals closely linked to Mr. Clark. His spouse holds 49,746 shares indirectly, while The Burrow Trust holds 1,624,907 shares. Similar to the primary trust, Mr. Clark disclaims beneficial ownership of the shares held by The Burrow Trust, except for his pecuniary interest.

These insider transactions occur against a backdrop of significant stock price volatility for BETA Technologies. The company's shares have declined approximately 54% over the past year. As of the latest reporting, the stock was trading at $17.38. Despite this decline, analysis from InvestingPro suggests that the stock may be undervalued at current levels. A Fair Value estimate indicates potential upside, and the platform tracks over eight additional ProTips for BETA. These insights highlight the company's strong balance sheet and impressive gross profit margins of 65.52%.

In other recent developments, BETA Technologies reported its Q1 2026 earnings results. The financial disclosure revealed a larger-than-anticipated loss per share. The company posted an earnings per share of -$0.53, which fell below the forecasted -$0.45. However, revenue performance exceeded expectations, coming in at $10.1 million. Alongside these financial results, the company held its 2026 Annual Meeting of Stockholders. During this meeting, shareholders elected John Abele, James McConville, and John Slattery as Class I directors for a three-year term.

Analyst sentiment regarding BETA Technologies has also seen recent adjustments. Analysts from BTIG and Cantor Fitzgerald have modified their price targets for the stock. BTIG lowered its price target to $33 from $40, citing revised delivery expectations, while maintaining a Buy rating. Cantor Fitzgerald reduced its price target to $31 from $38 but kept an Overweight rating. Cantor Fitzgerald expressed optimism about the company's strategy to first certify a conventional takeoff and landing aircraft. These developments reflect a mix of financial performance and strategic decisions that are currently shaping the company's outlook.

Risks

  • BETA Technologies faces financial risks as evidenced by its Q1 2026 loss per share of -$0.53, which was larger than the anticipated -$0.45, indicating potential profitability challenges in the aerospace manufacturing sector.
  • The stock has declined approximately 54% over the past year, suggesting market volatility and potential investor confidence issues in the electric aircraft technology market.
  • Revised delivery expectations cited by BTIG as a reason for lowering the price target highlight operational risks related to production timelines in the advanced aviation sector.

More from Insider Trading

Precigen CFO Thomasian Executes $1.1M Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Revolution Medicines Director Sushil Patel Executes Pre-Arranged Stock Sales Worth $1.05 Million Jul 1, 2026 Alphabet Executive Walker Offloads $3.14M in Class C Shares Under Pre-Arranged Plan Jul 1, 2026 Precigen COO Rutul Shah Executes $251K Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Precigen CEO Helen Sabzevari Executes $2.04 Million Stock Sale Following 262% Surge Jul 1, 2026